Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022Found: Pericardial disorders NEC Pericardial effusion 1 0 Pulmonary valvular disorders Pulmonary valve
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: Coronary artery disorders NEC Coronary artery stenosis 1 1 Coronary artery thrombosis 1 0 Heart
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022Found: and symptoms NEC Palpitations 8 0 Endocarditis NEC Endocarditis noninfective 1 1 Heart
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 7 November 2022Found: and symptoms NEC Palpitations 8 0 Endocarditis NEC Endocarditis noninfective 1 1 Heart
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 14 November 2022Found: and symptoms NEC Palpitations 8 0 Endocarditis NEC Endocarditis noninfective 1 1 Heart
Aug. 29 2023
Source Page: Addressing palliative and end of life care needs for people living with heart failure: a revised framework for integrated care systemsFound: Addressing palliative and end of life care needs for people living with heart failure: a revised framework
Jan. 12 2024
Source Page: I. Letter dated 11/01/2024 from Baroness Neville-Rolfe to the Deposited Papers Clerk regarding the Office of National Statistics' Annual Abstract of Deaths for deposit in the House Libraries. 1p. II. Deaths registered in England and Wales, 2022. 442pFound: )Bronchitis, emphysema, and other chronic pulmonary disease (J40 to J44)Gastric and duodenal ulcer (K25
Sep. 05 2024
Source Page: Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis (Review of TA756) [ID5115]Found: Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis (Review of TA756) [
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: Arteriosclerosis coronary artery 1 0 Coronary artery stenosis 1 1 Coronary artery thrombosis 1 0 Heart
Sep. 11 2024
Source Page: Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and overFound: This means LDL -C accumulat es in t he blood, leading t o aor tic valve disease in childhood and r esultant